-
-
Call more information
660-596-2224 -
The Institute for Safe Medicine Practices reviewed 12 months of FDA data and identified hundreds of cases of acute liver failure in patients taking direct-acting antivirals for hepatitis C. In October, the FDA announced that it was adding a boxed warning to the labels of direct-acting antivirals after identifying 24 cases of hepatitis B reactivation. […]
Read MoreAuthors: Michael J. Murray et al Crit Care Med. 2016;44(11):2079-2103. Objective: To update the 2002 version of “Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.” Design: A Task Force comprising 17 members of the Society of Critical Medicine with particular expertise in the use of neuromuscular-blocking agents; a Grading of Recommendations Assessment, Development, […]
Read MoreFor patients with severe, chronic back and leg pain, a new high-frequency spinal cord stimulation (SCS) technique provides superior clinical outcomes, compared to conventional low-frequency SCS, reports a clinical trial in the November issue of Neurosurgery. The new ‘HF10’ technique offers lasting reductions in back and leg pain after other treatments have failed, according to […]
Read MoreThe implementation of an evidence-based, multimodal pain regimen after Roux-en-Y gastric bypass (LRYGB) was associated with a significant decrease in narcotic requirements as well as maximum postoperative pain scores, according to a study presented here on November 1 at Obesity Week 2016, the Annual Meetings of the American Society for Metabolic & Bariatric Surgery (ASMBS) […]
Read MoreAuthors: Magdalena Serra et al BMC Anesthesiol. 2016;16(78) Background: The use of elastomeric devices for ambulatory intravenous pain treatment in Major Ambulatory Surgery (MAS) has been described to improve postoperative pain management. The objective of the study was to describe the first 3 years experience of the use of elastomeric devices for ambulatory intravenous pain treatment in […]
Read More